Submission Details
| 510(k) Number | K242190 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 25, 2024 |
| Decision Date | March 05, 2025 |
| Days to Decision | 223 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K242190 is an FDA 510(k) clearance for the Access Cortisol; DxC 500i Clinical Analyzer, a Radioimmunoassay, Cortisol (Class II — Special Controls, product code CGR), submitted by Beckman Coulter, Inc. (Brea, US). The FDA issued a Cleared decision on March 5, 2025, 223 days after receiving the submission on July 25, 2024. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1205.
| 510(k) Number | K242190 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 25, 2024 |
| Decision Date | March 05, 2025 |
| Days to Decision | 223 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CGR — Radioimmunoassay, Cortisol |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1205 |